Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Partnership with Biofield focuses on breast cancer testing system in China
September 8th, 2005
Bridgetech Holdings International, Inc., (BGTH) announced that in partnership with Biofield Corp. (Biofield: OTC: BZET) they are to begin testing, marketing and distributing the Biofield Breast Proliferation Detection System (BDS) in the People's Republic of China (PRC), the Hong Kong Special Administrative Region of the PRC, the Republic of China (Taiwan), Vietnam and Singapore. "We are very pleased to join forces with Biofield in the fight against breast cancer," said Michael Chermak, president and CEO of Bridgetech. "BDS is a leap forward in detection and will be an invaluable tool in the widespread screening of this terrible disease. It is uniquely suited for Asian...
Source: Women's Health Weekly (2005-09-08)
|
